COMMUNIQUÉS West-GlobeNewswire

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

24/01/2024 - 13:00

FDA requesting clarifications around chemistry, manufacturing and controls and additional information related to immunogenicity CRL does not impact commercial availability of EGRIFTA SV ® , the F4 formulation of [...]

Theratechnologies reçoit une lettre de non-approbation (CRL) de la FDA concernant son supplément à la licence de produit biologique (sBLA) pour la formulation F8 de la tésamoréline

24/01/2024 - 13:00

La FDA demande des clarifications sur la chimie, la fabrication et les contrôles ainsi que des informations supplémentaires sur l'immunogénicité La CRL n'affecte pas la disponibilité commerciale d'EGRIFTA SV MD , la [...]

CENTOGENE Receives French Research Tax Credit Accreditation

24/01/2024 - 12:30

Partners able to claim up to 30% tax relief CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers [...]

Valhalla’s Innovative Extra Strength Troches Set to Hit Dispensary Shelves Throughout Pennsylvania

24/01/2024 - 12:30

TerrAscend expands its Valhalla product lineup to include one of the first 100mg edibles in The Keystone State TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) ( [...]

RadNet’s Arizona Diagnostic Radiology Group Joint Venture Acquires Seven Outpatient Imaging Centers in Phoenix, Arizona

24/01/2024 - 12:00

LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces that its joint ventured [...]

EmpowerHER: A new professional network for female leaders in health launches

24/01/2024 - 12:00

OTTAWA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative milestone in championing and supporting women within Canadian [...]

KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide

24/01/2024 - 11:16

RIYADH, Saudi Arabia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University's prestigious list, marking them among the 'top 2% most- [...]

Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases

24/01/2024 - 11:05

WÜRZBURG, Germany and CAMBRIDGE, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) -- DAHW German Leprosy and Tuberculosis Relief Association and BelleTorus Corporation (“Belle.ai”) have joined forces with Senegal’s Ministry of [...]

Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

24/01/2024 - 11:00

Acquisition enriches Kyowa Kirin’s portfolio, enables the development of numerous promising candidates with a clinically differentiated platform, and helps to resource ongoing and future launches of Libmeldy® ( [...]

Coloplast Finance B.V. - Change of Auditor

24/01/2024 - 09:32

Today, 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting at which Ernst & Young Accountants LLP was elected as Coloplast Finance B.V.’s auditors. Attachment [...]

Coloplast Finance B.V. - Decisions at the Annual General Meeting

24/01/2024 - 09:30

On 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S, approved the annual report for the financial year 2022/23. In addition, [...]

IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine

24/01/2024 - 09:00

Board strengthened with appointments of Tim Haines (Abingworth) as Non-executive Chair and Dr Oliver Nussbaumer (co-founder of GammaDelta Therapeutics and Adaptate Biotherapeutics) and Dr Inga Deakin (Molten Ventures) [...]

Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders

24/01/2024 - 09:00

PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders First demonstration of efficacy in disease-relevant [...]

Sirona Biochem Corporate Update January 2024

24/01/2024 - 07:30

VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides the following update: Dear shareholders, We are pleased to provide an update [...]

Everest Group recognizes Indegene as a Leader in Life Sciences Digital Services Specialist PEAK Matrix® Assessment 2024

24/01/2024 - 07:13

PRINCETON, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Everest Group, a leading global research and consulting firm, has recognized Indegene as a Leader in its Life Sciences Digital Services Specialist PEAK Matrix ® [...]

SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

23/01/2024 - 23:58

SIOUX FALLS, S.D., Jan. 23, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics , Inc. (Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti- [...]

Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock

23/01/2024 - 23:45

SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to [...]

Vision Sensing Acquisition Corp. Received Nasdaq Delisting Determination Letter and Intends to Appeal the Determination and Request a Stay Pending the Appeal Hearing

23/01/2024 - 23:43

NEW YORK, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ” or “ VSAC ”), a special purpose acquisition company, announced today that it received a staff [...]

Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell

23/01/2024 - 23:00

BURLINGAME, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, is deeply saddened to announce the passing of Edith P. Mitchell, M.D., a [...]